Cyclodextrin-Modified Nanomaterials for Drug Delivery
In recent years, the use of CD derivatives in combination with nanomaterials has shown to be a promising strategy for
Tag: Nanoparticles
Cyclodextrin-based nanoparticles for pharmaceutical applications: a review
Cyclodextrin-conjugated nanoparticles combine the advantages of cyclodextrins and nanoparticles: enhanced water solubility and drug loading, targeted drug delivery with minimum
International Symposium of Drug Delivery Systems (SDDS-2022)
The 10th Annual International Symposium of Drug Delivery Systems (SDDS-2022) will be held during May 11-13, 2022 in Tokyo, Japan. The SDDS-2022
Nonviral DNA Delivery System with Supramolecular PEGylation Formed by Host–Guest Pseudo-Block Copolymers
A cationic supramolecular system based on host–guest pseudoblock copolymers was developed for nonviral DNA delivery. In this system, the macromolecular
Special Issue “Polymeric Nanoparticles in Drug Delivery”
Special Issue “Polymeric Nanoparticles in Drug Delivery“, in the OPEN ACCESS journal /Applied Sciences/ (ISSN 2076-3417; Impact Factor: 2.474), is
Central nervous system delivery of molecules across the blood-brain barrier
Therapies targeting neurological conditions such as Alzheimer’s or Parkinson’s diseases are hampered by the presence of the blood-brain barrier (BBB).
The story of cyclodextrin metal–organic frameworks and their applications from Nobel-prize laureate, F. Stoddart
Cyclodextrin-based metal–organic frameworks (CD-MOFs), derived from γ-cyclodextrin (γ-CD) and alkali metal cations, constitute a class of porous, renewable, and edible
Cinchonidine-functionalized β-cyclodextrin in catalysis
A short communication from the groups of Univ. Artois, Università degli Studi di Palermo and Charles University, Prague showed that
CD-based Nanoparticles from CNR-ISMN Institute of Nanostructured Materials
The research group of CNR-ISMN Institute of Nanostructured Materials has developed various CDE-based nanoparticles, nanoassemblies for biomedical applications. Nanoassemblies based
Dendrimer-based formulation of remdesivir
Current formulations of remdesivir are required to be administered intravenously due to the drug’s low solubility, with each infusion taking